
GC41631
BPIQ-I
Also known as N-(3-bromophenyl)-3-methylimidazo[4,5-g]quinazolin-8-amine
BPIQ-I is a quinazoline that inhibits the tyrosine kinase activity of the epidermal growth factor receptor (IC50 = 0·025 nM)
ChemicalCAS174709-30-9MW354.2FormulaC16H12BrN5
- CAS number
- 174709-30-9
- Molecular weight
- 354.2
- Formula
- C16H12BrN5
- Solubility
- DMF: 20 mg/ml,DMSO: 30 mg/ml,DMSO:PBS (pH 7·2) (1:1): 0·5 mg/ml
- InChIKey
- YAMAGACQNDAKFB-UHFFFAOYSA-N
- Catalogue number
- GC41631
- Brand
- GLPBIO
Computed properties PubChem CID 2427 · XLogP 3.6 · TPSA 55.6 Ų · H-bond donors 1
- XLogP
- 3.6
- TPSA
- 55.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 2
- Heavy atoms
- 22
SMILES CN1C=NC2=C1C=C3C(=C2)C(=NC=N3)NC4=CC(=CC=C4)Br
Computed descriptors from PubChem (CID 2427), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il